2.3. Data Collection, Randomization, Blinding, and Bias Control Method
DISEASES
Data were collected from medical records and patient interviews. All patients who participated in the study had signed informed consent forms. All patients were interviewed twice; the second time was 1 month apart from the first, collecting information about changes after the intervention. Counseling for the intervention group was conducted in the initial interview and 1 month after. The interview contents include (1) Patient information collection form; (2) Knowledge of diseases and drugs; (3) Compliance assessment using the general medication adherence scale (GMAS) (We used a random sampling method by selecting all patients who met the criteria during the study period. The website (Information bias may occur due to: (1) The patients not correctly remembering or understanding the question; (2) The interviewer not fully expressing the question’s meaning during the interview. Remedial measures include: (1) Clearly explaining the research purpose and calling for the support of the patients; (2) Questioning more clearly; (3) Guiding the patient to answer specific and detailed right at the beginning of the interview; (4) Directly explaining when requested; (5) Combining viewing medical records and prescriptions while interviewing patients or family members to understand the patient’s follow-up status and medications.